97 related articles for article (PubMed ID: 8612392)
1. Phenytoin in the treatment of cocaine abuse: a double-blind study.
Crosby RD; Pearson VL; Eller C; Winegarden T; Graves NL
Clin Pharmacol Ther; 1996 Apr; 59(4):458-68. PubMed ID: 8612392
[TBL] [Abstract][Full Text] [Related]
2. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.
Halikas JA; Crosby RD; Pearson VL; Graves NM
Clin Pharmacol Ther; 1997 Jul; 62(1):89-105. PubMed ID: 9246023
[TBL] [Abstract][Full Text] [Related]
3. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D
Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled screening trial of celecoxib for the treatment of cocaine dependence.
Reid MS; Angrist B; Baker S; Woo C; Schwartz M; Montgomery A; Majewska D; Robinson J; Rotrosen J
Addiction; 2005 Mar; 100 Suppl 1():32-42. PubMed ID: 15730348
[TBL] [Abstract][Full Text] [Related]
5. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.
Winhusen T; Somoza E; Ciraulo DA; Harrer JM; Goldsmith RJ; Grabowski J; Coleman FS; Mindrum G; Kahn R; Osman S; Mezinskis J; Li SH; Lewis D; Horn P; Montgomery MA; Elkashef A
Drug Alcohol Depend; 2007 Dec; 91(2-3):141-8. PubMed ID: 17629631
[TBL] [Abstract][Full Text] [Related]
7. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency.
Jenkins SW; Warfield NA; Blaine JD; Cornish J; Ling W; Rosen MI; Urschel H; Wesson D; Ziedonis D
Psychopharmacol Bull; 1992; 28(1):21-6. PubMed ID: 1609038
[TBL] [Abstract][Full Text] [Related]
8. Ritanserin in the treatment of cocaine dependence.
Johnson BA; Chen YR; Swann AC; Schmitz J; Lesser J; Ruiz P; Johnson P; Clyde C
Biol Psychiatry; 1997 Nov; 42(10):932-40. PubMed ID: 9359980
[TBL] [Abstract][Full Text] [Related]
9. The convergent validity of the Drug Impairment Rating Scale for Cocaine.
Halikas JA; Crosby RD; Nugent SM
Psychopharmacol Bull; 1992; 28(3):315-8. PubMed ID: 1480736
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
Elkashef A; Holmes TH; Bloch DA; Shoptaw S; Kampman K; Reid MS; Somoza E; Ciraulo D; Rotrosen J; Leiderman D; Montgomery A; Vocci F
Addiction; 2005 Mar; 100 Suppl 1():91-101. PubMed ID: 15730353
[TBL] [Abstract][Full Text] [Related]
13. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
Hernández R; Fernández Mde L; Miranda G; Suástegui R
Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
[TBL] [Abstract][Full Text] [Related]
14. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
Yegnanarayan R; Mahesh SD; Sangle S
Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
[TBL] [Abstract][Full Text] [Related]
16. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
Brown ES; Gorman AR; Hynan LS
J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684
[TBL] [Abstract][Full Text] [Related]
18. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients.
Margolin A; Avants SK; Kosten TR
Am J Drug Alcohol Abuse; 1995 Nov; 21(4):469-81. PubMed ID: 8561098
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
Levin FR; Evans SM; Brooks DJ; Garawi F
Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations.
Batki SL; Manfredi LB; Jacob P; Jones RT
J Clin Psychopharmacol; 1993 Aug; 13(4):243-50. PubMed ID: 8376611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
